
Interpace Biosciences IDXG
€ 1.55
0.0%
Quartalsbericht 2026-Q1
hinzugefügt 12.05.2026
Interpace Biosciences EV 2011-2026 | IDXG
EV Jährlich Interpace Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.3 M | 19.7 M | 24.6 M | 32.3 M | 53.9 M | 41.7 M | 82.3 M | 34.8 M | 15.9 M | 42.2 M | 50.5 M | 95.9 M | 77.5 M | 102 M | 85.3 M | -7.84 M | -72.5 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 102 M | -72.5 M | 40.9 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.32 | -19.18 % | $ 1.76 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 112.44 | -0.71 % | $ 34.2 B | ||
|
Castle Biosciences
CSTL
|
463 M | $ 19.2 | 1.69 % | $ 557 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.88 | -1.91 % | $ 480 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
15.3 B | $ 140.85 | -1.67 % | $ 22.4 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 19.88 | -2.98 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 94.55 | -2.2 % | $ 6.38 B | ||
|
Medpace Holdings
MEDP
|
14 B | $ 419.78 | 0.15 % | $ 12.1 B | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 051.07 | 0.88 % | $ 21.7 B | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Myriad Genetics
MYGN
|
598 M | $ 3.65 | 0.69 % | $ 338 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 8.32 | -0.54 % | $ 1.07 B | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
432 M | $ 18.64 | -1.53 % | $ 417 M | ||
|
Natera
NTRA
|
5.53 B | $ 188.14 | -4.45 % | $ 18.5 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 155.97 | -1.98 % | $ 7.73 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 25.36 | -0.55 % | $ 24 B | ||
|
Guardant Health
GH
|
15.2 B | $ 93.95 | -4.77 % | $ 11.8 B | ||
|
Personalis
PSNL
|
380 M | $ 6.56 | -2.24 % | $ 585 M | ||
|
Senseonics Holdings
SENS
|
376 M | $ 5.71 | -1.89 % | $ 238 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 118.48 | 1.19 % | $ 9.77 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | $ 52.98 | -0.02 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.36 | -2.07 % | $ 5.42 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 252.76 | -0.5 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
186 B | - | - | $ 167 B | ||
|
Trinity Biotech plc
TRIB
|
327 M | $ 0.56 | -3.75 % | $ 201 M | ||
|
Celcuity
CELC
|
5.57 B | $ 134.53 | -0.14 % | $ 6.29 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 48.6 | -8.22 % | $ 2.91 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 8.32 | -1.25 % | $ 1.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 187.2 | -0.39 % | $ 20.8 B | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M |